Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Gastroenterology
  • Gastroenterology News
  • Investigational human...

Investigational human monoclonal antibody shows potential for treating chronic hepatitis B and hepatitis D

Written By : Dr. Kamal Kant Kohli Published On 2023-08-09T06:00:33+05:30  |  Updated On 9 Aug 2023 11:20 AM IST
Investigational human monoclonal antibody shows potential for treating chronic hepatitis B and hepatitis D
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

USA: A recent preclinical study published in the Journal of Hepatology has shown the potential of an engineered investigational human monoclonal antibody for the treatment of chronic hepatitis B and hepatitis D.

Based on the results of the study involving the Heidelberg University Hospital, German Center for Infection Research (DZIF), US company Vir Biotechnology, and University Medical Center Hamburg-Eppendorf, clinical trials with the monoclonal antibody VIR-3434 are ongoing.

Affecting hundreds of millions of people, chronic hepatitis B (HBV) is a widespread global health problem for which there is as yet no cure. Chronic hepatitis B virus infection poses a severe threat to approximately 300 million people worldwide, leading to liver disease and cancer. Approximately four percent of affected persons are chronically coinfected with the hepatitis delta virus (HDV), which exacerbates the gravity of the disease. Current treatments provide only limited cure rates and necessitate indefinite times of therapy.

A team around DZIF scientists from Heidelberg and Hamburg-Eppendorf supported the preclinical development of VIR-3434, a monoclonal antibody (mAb) discovered by Vir Biotechnology, Inc., that specifically targets the hepatitis B surface antigen (HBsAg) located in the viral envelope. This preclinical study shows how the engineered investigational human monoclonal antibody effectively prevents viral dissemination and reduces the amounts of viral particles and antigen in a mouse model for HBV/HDV coinfection.

A targeted approach

The researchers isolated and screened several monoclonal antibodies from memory B cells of HBV-vaccinated individuals that specifically target a conformational epitope (an epitope formed through the three-dimensional folding of the protein bringing distant amino acids together) within the antigenic loop of the small hepatitis B surface antigen. Among a series of more than 30 generated antibodies, which were tested using the most advanced in vitro infection system available and established at Heidelberg University Hospital, one mAb named HBC34 demonstrated potent neutralisation activity against HBV and HDV. The latter is a satellite virus that hijacks HBV surface proteins to infect human hepatocytes. The activity has been shown to be pan-genotypic, providing evidence that HBC34 neutralises all known genotypes of HBV and HDV. Modifications in the structure of the HBC34 mAb for improved potency generated VIR-3434 as a promising mAb candidate for clinical development.

“Aside from the potent neutralisation activity of VIR-3434, we engineered the Fc-portion of the mAb-the tail end of the antibody molecule that is crucial in the immune response-to increase binding to certain immune cells,” explains the co-first and corresponding author of the paper, Dr Florian Lempp, director of virology at Vir. “VIR-3434 has the potential to rapidly eliminate both viral and subviral particles from circulation.”

The researchers then tested VIR-3434’s neutralisation capability in a human liver-chimeric mouse model developed at the University Medical Center Hamburg-Eppendorf (UKE) by the team around Prof. Maura Dandri, a DZIF-scientist on viral hepatitis at UKE and co-author of the paper. The livers of these mice are populated with primary human hepatocytes-the only cell type infected by HBV and HDV in humans. The in vivo studies were essential to demonstrate that the in vitro selected mAb, VIR-3434, was able to block viral dissemination in the liver of both HBV-infected and HBV/HDV-coinfected mice.

“We found that VIR-3434 not only neutralises HBV and HDV infection with high potency in vivo,” explains the co-first author of the study Dr Tassilo Volz, “but it also effectively reduces viraemia-the number of viruses in the bloodstream-and the levels of circulating viral antigens in chronically infected animals.”

"VIR-3434 may provide a potential new option for treating patients with chronic hepatitis B and D, and aid in the prevention of these diseases. The antibody's strong neutralisation properties and promising results in our preclinical infection model may offer hope for patients worldwide," adds Prof. Dandri.

Testing VIR-3434 in the clinic

Based on the findings, clinical studies to ascertain the safety and efficacy of VIR-3434 in human subjects are already underway. The researchers hope that VIR-3434, which is also being studied in combination with other investigational agents, may provide a much-needed therapy to combat chronic hepatitis B and D and the devastating consequences of chronic infection with these viruses.

“The successful isolation and characterisation of VIR-3434 could mark a significant turning point in hepatitis B and D treatment. If further validated through clinical trials, this mAb may offer an important therapeutic option for patients with chronic hepatitis B and D,” emphasises co-author and DZIF-scientist Prof. Stephan Urban of Heidelberg University Hospital.

The described research on VIR-3434, which incorporates Xencor Xtend™ technology (an innovative platform that allows the prolongation of the half-life of antibodies), is the result of a successful collaboration of scientists within the German Center for Infection Research (DZIF) and with the industry partner Vir. The project fits into the DZIF bridging topic “Antibody-based therapies”, which aims to connect experts across DZIF’s different research areas to advance the development, production and clinical testing of therapeutic monoclonal antibodies.

Reference:

Florian A. Lempp, Tassilo Volz, Elisabetta Cameroni, Fabio Benigni, Jiayi Zhou, Laura E. Rosen, Julia Noack, Fabrizia Zatta, Hannah Kaiser, Siro Bianchi, Gloria Lombardo, Stefano Jaconi, Lucia Vincenzetti, Hasan Imam, Leah B. Soriaga, Nadia Passini, David M. Belnap, Andreas Schulze, Marc Lütgehetmann, Amalio Telenti, Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice, Published:July 15, 2023DOI:https://doi.org/10.1016/j.jhep.2023.07.003.

Journal of Hepatologymonoclonal antibodychronic hepatitis Bhepatitis D
Source : Journal of Hepatology
Dr. Kamal Kant Kohli
Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Show Full Article
Next Story

Editorial

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

Aspirin in Primary Prevention- When to Consider?

Aspirin in Primary Prevention- When to Consider?

Featured image representing medico legal

What's the Role of Expert Opinion in Medical Negligence?

7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

View All

Journal Club Today

High Blood Pressure in Children Tied to Mothers Pregnancy Health: NIH Study Finds

High Blood Pressure in Children Tied to Mother's Pregnancy Health: NIH Study Finds

View All

Health News Today

Health Bulletin 10/ May/ 2025

Health Bulletin 10/ May/ 2025

View All
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok